EyePoint Pharma Files 2024 10-K
Ticker: EYPT · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1314102
| Field | Detail |
|---|---|
| Company | Eyepoint Pharmaceuticals, Inc. (EYPT) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
Related Tickers: EYPT
TL;DR
EYPT filed its 2024 10-K. Looks like they're still active with their incentive plans and ATM offerings.
AI Summary
EyePoint Pharmaceuticals, Inc. filed its 2024 10-K report on March 6, 2025, detailing its fiscal year ending December 31, 2024. The company, formerly known as pSivida Corp., is based in Watertown, MA. The filing covers financial performance and business operations for the period, including references to its 'TwoThousandSixteenIncentivePlan' and 'AtTheMarketOffering' activities.
Why It Matters
This 10-K filing provides a comprehensive overview of EyePoint Pharmaceuticals' financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, EyePoint faces inherent risks related to drug development, regulatory approvals, market competition, and financial performance, which are detailed in its 10-K filing.
Key Players & Entities
- EyePoint Pharmaceuticals, Inc. (company) — Filer of the 10-K
- pSivida Corp. (company) — Former name of EyePoint Pharmaceuticals
- 2024-12-31 (date) — Fiscal year end
- 2025-03-06 (date) — Filing date
- Watertown, MA (location) — Company headquarters
- TwoThousandSixteenIncentivePlan (plan) — Mentioned in filing
- AtTheMarketOffering (offering) — Mentioned in filing
FAQ
What was EyePoint Pharmaceuticals' fiscal year end for this filing?
The fiscal year end was December 31, 2024.
When was this 10-K filing submitted to the SEC?
The filing was submitted on March 6, 2025.
What was EyePoint Pharmaceuticals' former company name?
The company was formerly known as pSivida Corp. and pSivida LTD.
Where is EyePoint Pharmaceuticals headquartered?
The company is headquartered in Watertown, MA.
Are there any specific plans or offerings mentioned in the filing metadata?
Yes, the metadata references 'TwoThousandSixteenIncentivePlan' and 'AtTheMarketOffering'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding EyePoint Pharmaceuticals, Inc. (EYPT).